CertaraCERT
Market Cap: $1.83B
About: Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.
Employees: 1,391
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
0% more funds holding in top 10
Funds holding in top 10: 2 [Q1] → 2 (+0) [Q2]
0% less funds holding
Funds holding: 217 [Q1] → 216 (-1) [Q2]
0.77% less ownership
Funds ownership: 75.33% [Q1] → 74.55% (-0.77%) [Q2]
3% less first-time investments, than exits
New positions opened: 28 | Existing positions closed: 29
19% less repeat investments, than reductions
Existing positions increased: 70 | Existing positions reduced: 86
23% less capital invested
Capital invested by funds: $2.15B [Q1] → $1.66B (-$493M) [Q2]
41% less call options, than puts
Call options by funds: $133K | Put options by funds: $226K
Research analyst outlook
4 Wall Street Analysts provided 1 year price targets over the past 3 months
4 analyst ratings
UBS Dan Leonard 38% 1-year accuracy 3 / 8 met price target | 40%upside $16 | Neutral Maintained | 7 Aug 2024 |
Baird Joe Vruwink 35% 1-year accuracy 9 / 26 met price target | 58%upside $18 | Neutral Maintained | 7 Aug 2024 |
Keybanc Scott Schoenhaus 36% 1-year accuracy 12 / 33 met price target | 76%upside $20 | Overweight Maintained | 11 Jul 2024 |
Barclays Luke Sergott 65% 1-year accuracy 22 / 34 met price target | 40%upside $16 | Equal-Weight Maintained | 28 Jun 2024 |